Lymphomatoid papulosis misdiagnosed as pityriasis lichenoides et varioliformis acuta: Two case reports and a literature review

Zheng,Yan; Jia,Jinjing; Tian,Qiong; Dong,Xinyu; Wang,Xin; Ying,Zhaoxia; Xiao,Shengxiang; Li,Wensheng

doi:10.3892/etm.2014.2006

Lymphomatoid papulosis misdiagnosed as pityriasis lichenoides et varioliformis acuta: Two case reports and a literature review

Authors:
- Yan Zheng
- Jinjing Jia
- Qiong Tian
- Xinyu Dong
- Xin Wang
- Zhaoxia Ying
- Shengxiang Xiao
- Wensheng Li
View Affiliations

Affiliations: Department of Dermatology, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi 710004, P.R. China, Department of Pathology, The Third Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi 710068, P.R. China
Published online on: October 7, 2014 https://doi.org/10.3892/etm.2014.2006
Pages: 1927-1933

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The aim of this study was to improve the level of diagnosis and differential diagnosis of lymphomatoid papulosis (LyP). Two cases of type B LyP were identified and the literature was reviewed to summarize the clinical outcomes and pathology of LyP and its treatment. The two patients exhibited symptoms with papulonodular lesions, the centers of which gradually underwent ulceration and necrosis. CD30, a helper T‑cell marker specifically expressed in tumor cells was analyzed by immunohistochemical staining and the result showed that CD30‑negative or only scattered CD30‑positive cells were present. Therefore, a diagnosis of type B LyP was made. A fairly good curative effect was achieved following treatment with retinoic acid, glucocorticoids and immunomodulatory drugs. LyP is a type of low‑level malignant lymphoma and is easily misdiagnosed as pityriasis lichenoides et varioliformis acuta and other diseases. In order to avoid under diagnosis and misdiagnosis, doctors should evaluate suspected patients by histopathological and immunohistochemical examination.

View Figures

View References

1	Zic JA: Lymphomatoid papulosis treatment & management. Medscape Website. Available at: http://emedicine.medscape.com/article/1098954-treatmenturi. Accessed January 24, 2012
2	Fernández-Guarino M, Carrillo-Gijón R and Jaén-Olasolo P: Lymphomatoid papulosis: clinical and pathological findings in 18 patients. Actas Dermosifiliogr. 103:388–393. 2012.(In Spanish).
3	Martorell-Calatayud A, Hernández-Martín A, Colmenero I, et al: Lymphomatoid papulosis in children: report of 9 cases and review of the literature. Actas Dermosifiliogr. 101:693–701. 2010.(In Spanish).
4	Magro CM and Crowson AN: CD30-positive lymphoproliferative disorders including lymphomatoid papulosis, borderline CD3-positive lymphoproliferative disease, anaplastic large cell lymphoma, and T-cell-rich CD30-positive large B cell lymphoma. The Cutaneous Lymphoid Proliferations: A Comprehensive Textbook of Lymphocytic Infiltrates of the Skin. Magro CM, Crowson AN and Mihm MC: John Wiley & Sons, Inc; Hoboken, NJ: pp. 440–444. 2007
5	Macaulay WL: Lymphomatoid papulosis. A continuing self-healing eruption, clinically benign - histologically malignant. Arch Dermatol. 97:23–30. 1968. View Article : Google Scholar : PubMed/NCBI
6	Willemze R, Jaffe ES, Burg G, et al: WHO-EORTC classification for cutaneous lymphomas. Blood. 105:3768–3785. 2005. View Article : Google Scholar : PubMed/NCBI
7	Willemze R and Meijer CJ: Classification of cutaneous T-cell lymphoma: from Alibert to WHO-EORTC. J Cutan Pathol. 33(Suppl 1): 18–26. 2006. View Article : Google Scholar : PubMed/NCBI
8	Slater DN: The new World Health Organization-European Organization for Research and Treatment of Cancer classification for cutaneous lymphomas: a practical marriage of two giants. Br J Dermatol. 153:874–880. 2005. View Article : Google Scholar
9	de Souza A, el-Azhary RA, Camilleri MJ, Wada DA, Appert DL and Gibson LE: In search of prognostic indicators for lymphomatoid papulosis: a retrospective study of 123 patients. J Am Acad Dermatol. 66:928–937. 2012.PubMed/NCBI
10	Laube S, Stephens M, Smith AG, et al: Lymphomatoid papulosis in a patient with atopic eczema on long-term ciclosporin therapy. Br J Dermatol. 152:1346–1348. 2005. View Article : Google Scholar : PubMed/NCBI
11	Leo AM and Ermolovich T: Lymphomatoid papulosis while on efalizumab. J Am Acad Dermatol. 61:540–541. 2009. View Article : Google Scholar : PubMed/NCBI
12	Park JH, Lee J, Lee JH, et al: Lymphomatoid papulosis in a patient treated with adalimumab for juvenile rheumatoid arthritis. Dermatology. 225:259–263. 2012. View Article : Google Scholar : PubMed/NCBI
13	Kim SK and Kim YC: Lymphomatoid papulosis after allogenic stem cell transplantation. Eur J Dermatol. 19:520–521. 2009.PubMed/NCBI
14	Atkins KA, Dahlem MM and Kohler S: A case of lymphomatoid papulosis with prominent myxoid change resembling a mesenchymal neoplasm. Am J Dermatopathol. 25:62–65. 2003. View Article : Google Scholar : PubMed/NCBI
15	Van Neer FJ, Toonstra J, Van Voorst Vader PC, et al: Lymphomatoid papulosis in children: a study of 10 children registered by the Dutch Cutaneous Lymphoma Working Group. Br J Dermatol. 144:351–354. 2001.PubMed/NCBI
16	Chen L, Jin HZ, Yin HL, et al: Lymphomatoid papulosis. Study on the prevention and treatment of tumor. Zhong Liu Fang Zhi Yan Jiu. 27:130–132. 2000.(In Chinese).
17	Willemze R, Meyer CJ, Van Vloten WA and Scheffer E: The clinical and histological spectrum of lymphomatoid papulosis. Br J Dermatol. 107:131–144. 1982. View Article : Google Scholar : PubMed/NCBI
18	Querfeld C, Kuzel TM, Guitart J and Rosen ST: Primary cutaneous CD30⁺ lymphoproliferative disorders: new insights into biology and therapy. Oncology (Willston Park). 21:689–696; discussion 699–700. 2007.
19	Heald P, Subtil A, Breneman D and Wilson LD: Persistent agmination of lymphomatoid papulosis: an equivalent of limited plaque mycosis fungoides type of cutaneous T-cell lymphoma. J Am Acad Dermatol. 57:1005–1011. 2007. View Article : Google Scholar : PubMed/NCBI
20	Shao Z, Zuo C, Ge L, et al: Lymphomatoid papulosis: Case report and literature review. Wei Xun Huan Xue Za Zhi. 22:34–36. 2012.(In Chinese).
21	Saggini A, Gulia A, Argenyi Z, et al: A variant of lymphomatoid papulosis simulating primary cutaneous aggressive epidermotropic CD8⁺ cytotoxic T-cell lymphoma: Description of 9 cases. Am J Surg Pathol. 34:1168–1175. 2010. View Article : Google Scholar : PubMed/NCBI
22	El Shabrawi-Caelen L, Kerl H and Cerroni L: Lymphomatoid papulosis: reappraisal of clinicopathologic presentation and classification into subtypes A, B, and C. Arch Dermatol. 140:441–447. 2004.PubMed/NCBI
23	Liao QL, Chen XD, Wang W, et al: The clinical pathological analysis of primary cutaneous CD30⁺ lymphoproliferative disease. Zhong Hua Pi Fu Ke Za Zhi. 44:151–154. 2011.(In Chinese).
24	Andersen RM, Larsen MS, Poulsen TS, et al: Lymphomatoid papulosis type D or an aggressive epidermotropic CD8(+) cytotoxic T-cell lymphoma? Acta Derm Venereol. 94:474–475. 2014. View Article : Google Scholar : PubMed/NCBI
25	Sim JH and Kim YC: CD8+ lymphomatoid lapulosis. Ann Dermatol. 23:104–107. 2011. View Article : Google Scholar
26	Hoetzenecker W, Guenova E, Hoetzenecker K, et al: Successful treatment of recalcitrant lymphomatoid papulosis in a child with PUVA-bath photochemotherapy. Eur J Dermatol. 19:646–647. 2009.PubMed/NCBI
27	Coelho JD, Afonso A and Feio AB: Regional lymphomatoid papulosis in a child - treatment with a UVB phototherapy handpiece. J Cosmet Laser Ther. 12:155–156. 2010. View Article : Google Scholar : PubMed/NCBI
28	Rodrigues M, McCormack C, Yap LM, et al: Successful treatment of lymphomatoid papulosis with photodynamic therapy. Australas J Dermatol. 50:129–132. 2009. View Article : Google Scholar : PubMed/NCBI
29	Yip L, Darling S and Orchard D: Lymphomatoid papulosis in children: experience of five cases and the treatment efficacy of methotrexate. Australas J Dermatol. 52:279–283. 2011. View Article : Google Scholar : PubMed/NCBI
30	Shang SX, Chen H, Sun JF and Xu XL: Regional lymphomatoid papulosis successfully controlled by interferon α-2b and nitrogen mustard solution. Chin Med J (Engl). 126:3194–3195. 2013.PubMed/NCBI
31	Spires N and McGibbon D: Lymphomatoid papulosis improving on hormone-replacement therapy. Clin Exp Dermatol. 34:635–636. 2009. View Article : Google Scholar : PubMed/NCBI
32	Grange F and Bagot M: Prognosis of primary cutaneous lymphomas. Ann Dermatol Venereol. 129:30–40. 2002.(In French).
33	Nijsten T, Curiel-Lewandrowski C and Kadin ME: Lymphomatoid papulosis in children: a retrospective cohort study of 35 cases. Arch Dermatol. 140:306–312. 2004. View Article : Google Scholar : PubMed/NCBI
34	Kunishige JH, McDonald H, Alvarez G, Johnson M, Prieto V and Duvic M: Lymphomatoid papulosis and associated lymphomas: a retrospective case series of 84 patients. Clin Exp Dermatol. 34:576–581. 2009. View Article : Google Scholar : PubMed/NCBI
35	Bekkenk MW, Geelen FA, van Voorst Vader PC, et al: Primary and secondary cutaneous CD30(+) lymphoproliferative disorders: a report from the Dutch Cutaneous Lymphoma Group on the long-term follow-up data of 219 patients and guidelines for diagnosis and treatment. Blood. 95:3653–3661. 2000.PubMed/NCBI
36	Beljaards RC and Willemze R: The prognosis of patients with lymphomatoid papulosis associated with malignant lymphomas. Br J Dermatol. 126:596–602. 1992. View Article : Google Scholar : PubMed/NCBI
37	Tan AW and Giam YC: Lymphomatoid papulosis associated with recurrent cutaneous T-cell lymphoma. Ann Acad Med Singapore. 33:110–112. 2004.PubMed/NCBI
38	Rosen ST and Querfild C: Primary cutaneous T-cell lymphomas. Hematology Am Soc Hematol Educ Program. 2006:323–330. 2006. View Article : Google Scholar